ATG7 and metabolic dysfunction-associated steatotic liver disease: Furthermore, the investigators reported repressed hepatic expression of JMJD3, ATG7, LC3 and ULK1 in MASLD patients, and with the exception of ATG7, our data for MASLD patients agreed with their findings.